Skip to content
Research/Bioregulators/Bronchogen

Bronchogen

Synthetic lung/bronchial bioregulator. Studied for respiratory function improvement and pulmonary tissue support. Sequence: Ala-Glu-Asp-Leu.

Intelligence Profile

Science

Mechanism of Action

Based on the available evidence, Bronchogen appears to be a synthetic tetrapeptide with the sequence Ala-Asp-Glu-Leu that demonstrates potential regulatory effects on bronchial epithelial tissue, though the evidence base is limited.

Molecular Interactions

The primary evidence for Bronchogen's mechanism comes from studies examining its interaction with cellular components. Research has shown that this peptide can affect DNA thermostability, suggesting direct or indirect interactions with genetic material (PMID: 21240358). Additionally, studies indicate that short peptides similar to Bronchogen can penetrate cell nuclei and demonstrate specific interactions with DNA and oligonucleotides (PMID: 22117547).

Effects on Gene Expression

Limited evidence suggests that short exogenous peptides may regulate expression of specific gene families, including CLE, KNOX1, and GRF genes, though this research was conducted in tobacco plants rather than mammalian systems (PMID: 28371610). The relevance of these findings to human bronchial tissue remains unclear.

Tissue-Specific Effects

Research indicates that peptides like Bronchogen may have tissue-specific effects on cell differentiation, particularly during aging processes (PMID: 22808515). Studies in organotypic tissue cultures suggest these synthetic peptides function as biological regulators with varying effects in young versus aged tissue (PMID: 17152728).

Anti-inflammatory and Regenerative Properties

Some evidence suggests Bronchogen may have anti-inflammatory and regenerative effects on bronchial epithelium in animal models of obstructive lung pathology (PMID: 30199201, PMID: 26468022). However, the specific molecular pathways involved in these effects are not clearly defined in the available literature.

Evidence Limitations

The current evidence base for Bronchogen's mechanism of action is quite limited. Most studies are conducted in animal models or cell cultures, and the specific molecular pathways through which this peptide operates remain poorly characterized. More research is needed to establish a clear understanding of how Bronchogen functions at the cellular and molecular level in human respiratory tissue.